identifi
host
genet
factor
contribut
suscept
respiratori
infect
remain
central
challeng
understand
diseas
process
provid
new
insight
toward
precis
medicin
human
identif
diseas
modifi
lengthi
expens
endeavor
unpredict
success
rate
therefor
novel
approach
improv
diseas
model
requir
move
field
forward
among
respiratori
infect
caus
opportunist
pathogen
pseudomona
aeruginosa
retain
critic
role
clinic
set
p
aeruginosa
infect
associ
bacteri
pneumonia
patient
rang
patholog
clinic
phenotyp
owe
differ
etiolog
underli
condit
cystic
fibrosi
cf
chronic
obstruct
pulmonari
diseas
copd
accord
latest
world
health
organ
estim
million
peopl
worldwid
copd
cf
http
wwwwhoint
outcom
p
aeruginosa
infect
patient
chronic
respiratori
ill
difficult
predict
extrem
variabl
sever
pulmonari
condit
rang
mild
lifethreaten
recent
studi
suggest
outcom
mediat
presenc
microb
per
se
also
host
respons
particular
host
genet
factor
involv
multipl
genet
loci
presenc
polymorph
variant
influenc
patholog
trait
includ
airway
pathophysiolog
p
aeruginosa
infect
strike
exampl
cf
obstruct
lung
diseas
exclus
correl
mutat
diseasecaus
gene
cystic
fibrosi
transmembran
conduct
regul
cftr
individu
share
cftr
variant
exhibit
substanti
variat
sever
lung
diseas
explain
noncftr
genet
variat
howev
identifi
genet
diseas
modifi
genomewid
associ
studi
gwass
human
requir
larg
cohort
subject
detail
phenotyp
order
achiev
statist
signific
sinc
human
studi
timeconsum
costli
investig
whether
diseas
modifi
identifi
anim
model
collabor
cross
cc
mice
provid
use
tool
model
human
diseas
heterogen
term
genet
divers
chromosom
inbr
recombin
cc
line
genet
mosaic
eight
founder
haplotyp
three
founder
aj
common
laboratori
strain
three
strain
casteij
pwkphj
wsbeij
wild
deriv
ensur
maximum
genet
divers
two
strain
nodltj
nzohiltj
carri
genet
variant
predispos
medic
import
condit
consequ
cc
mice
greater
recombin
genet
variat
commerci
avail
refer
panel
high
map
resolut
suffici
sampl
size
drive
phenotyp
divers
almost
trait
interest
hallmark
cc
line
simul
previou
map
studi
indic
use
cc
popul
enabl
map
quantitativetrait
loci
qtl
mb
cc
mice
show
spectrum
pathogen
phenotyp
absent
classic
inbr
strain
make
particularli
use
forwardgenet
approach
patholog
manifest
across
cc
line
infect
similar
varieti
proport
spectra
clinic
diseas
caus
ebola
viru
mycobacterium
tuberculosi
west
nile
viru
sever
acut
respiratori
syndrom
sar
coronaviru
influenza
viru
power
resolut
map
cc
mice
demonstr
suscept
aspergillu
fumigatu
klebsiella
pneumonia
influenza
sar
coronaviru
howev
time
write
none
previou
find
cc
mice
yet
valid
function
translat
human
previous
demonstr
genet
divers
cc
mous
popul
display
wide
rang
herit
respons
respiratori
infect
p
aeruginosa
thu
genet
diseas
modifi
like
influenc
morbid
mortal
p
aeruginosa
pneumonia
remain
identifi
translat
human
use
cc
mice
diseas
model
map
genet
modifi
p
aeruginosa
respiratori
infect
function
valid
select
diseas
gene
confirm
relev
p
aeruginosa
pathophysiolog
use
conserv
synteni
mous
human
data
deriv
cohort
patient
infect
p
aeruginosa
identifi
human
candid
gene
within
correspond
synten
human
locu
data
demonstr
approach
gener
new
insight
translat
knowledg
genet
modifi
human
diseas
systemat
screen
suscept
p
aeruginosa
infect
carri
cc
line
includ
total
mice
femal
male
age
week
human
bronchopulmonari
infect
mimick
mice
expos
murin
airway
p
aeruginosa
clinic
strain
intratrach
inject
previous
describ
cc
line
monitor
mortal
surviv
time
segreg
analysi
phenotypictrait
distribut
carri
score
differ
cc
mous
strain
accord
mean
surviv
time
day
fig
see
also
data
set
supplement
materi
cc
line
exhibit
highli
variabl
suscept
p
aeruginosa
infect
rang
complet
resist
lethal
diseas
test
whether
trait
variat
within
popul
infect
mice
result
genet
factor
estim
broadsens
herit
previous
describ
obtain
valu
mean
surviv
time
fig
data
confirm
broad
rang
respons
p
aeruginosa
infect
cc
line
affect
genet
variabl
identifi
genet
loci
associ
p
aeruginosa
infect
perform
genomewid
associ
analysi
publicli
avail
highdens
singlenucleotid
polymorph
snp
genotyp
data
cc
mice
use
happi
softwar
base
r
languag
high
level
homozygos
line
use
genotyp
singl
repres
line
suffici
qtl
map
purpos
logist
regress
model
use
evalu
effect
gender
batch
initi
bodi
weight
trait
distribut
found
initi
bodi
weight
significantli
affect
surviv
trait
gender
batch
effect
use
haplotypebas
test
associ
detect
qtl
eight
cc
founder
haplotyp
permit
differ
phenotyp
effect
identifi
qtl
chromosom
chr
associ
mean
surviv
time
p
aeruginosa
infect
day
postinfect
day
peak
exceed
genomewid
permutationbas
signific
threshold
fig
permut
genom
scan
genomewid
maximum
neg
base
logarithm
p
valu
test
associ
logp
permut
genom
scan
qtl
day
postinfect
map
within
interv
mb
fig
next
use
merg
analysi
test
associ
individu
sequenc
variant
within
qtl
segreg
cc
founder
strain
fig
snp
strongest
associ
biallel
multiallel
howev
merg
analysi
imput
sequenc
variant
qtl
peak
identifi
snp
logp
valu
among
three
distinct
founder
strain
distribut
pattern
involv
contrast
aj
casteij
versu
rest
pwk
allel
ambigu
consist
founder
strain
pattern
moreov
founder
allel
effect
qtl
peak
shown
haplotyp
dosag
plot
fig
indic
haplotyp
associ
founder
aj
casteij
confer
resist
associ
founder
wsbeij
confer
suscept
associ
founder
midway
suggest
multipl
causal
variant
might
segreg
within
qtl
give
rise
haplotyp
differ
term
mean
surviv
time
infect
total
proteincod
sequenc
locat
within
interv
qtl
mb
two
gene
dpyd
within
interv
mb
fig
gene
within
qtl
priorit
score
use
signific
p
valu
qtl
contain
gene
one
point
signific
level
fig
protein
express
human
airway
particular
pneumocyt
bronchial
cell
inform
human
protein
atla
databas
tabl
identifi
gene
score
higher
candid
involv
p
aeruginosa
pneumonia
use
beegl
tool
diseas
gene
priorit
http
beegleesatkuleuvenb
queri
lung
infect
tabl
among
other
receptor
rank
one
promis
candid
encod
gproteincoupl
receptor
bind
bioactiv
signal
molecul
involv
sever
physiolog
process
includ
inflamm
mediat
viral
bacteri
infect
test
candid
involv
p
aeruginosa
infect
function
valid
mous
model
airway
infect
ask
whether
perturb
pathway
alter
outcom
p
aeruginosa
infect
use
select
antagonist
function
antagonist
induc
intern
mice
select
intermedi
suscept
p
aeruginosa
infect
challeng
dose
cfu
strain
condit
untreat
mice
die
p
aeruginosa
infect
give
window
opportun
evalu
either
benefici
detriment
effect
pharmacolog
treatment
treatment
p
aeruginosainfect
mice
result
significantli
higher
mortal
day
mice
infect
treat
correspond
vehicl
versu
control
ctrl
p
versu
ctrl
p
fig
fig
control
treatment
alon
noninfect
mice
show
mortal
addit
treatment
reduc
total
number
white
blood
cell
wbc
particularli
circul
lymphocyt
fig
fig
demonstr
effect
immunomodul
result
suggest
reduc
level
wbc
inhibit
worsen
outcom
p
aeruginosa
acut
respiratori
infect
translat
result
human
lung
diseas
use
synteni
portal
fig
find
human
locu
synten
murin
chr
mb
locat
chr
mb
human
genom
version
fig
analyz
wellcharacter
patient
cohort
p
aeruginosa
respiratori
infect
canadian
cf
gene
modifi
cohort
clinic
microbiolog
data
p
aeruginosa
infect
use
identifi
candid
gene
within
synten
region
test
region
genomewid
genet
associ
use
age
first
p
aeruginosa
infect
phenotyp
robust
commonli
collect
p
aeruginosa
phenotyp
clinic
sampl
previous
shown
associ
cf
modifi
gene
primari
analysi
follow
assess
specif
correl
phenotyp
includ
chronic
p
aeruginosa
infect
correl
first
p
aeruginosa
infect
p
lung
diseas
sever
specif
test
associ
squareroottransform
age
first
p
aeruginosa
infect
snp
chr
mb
individu
european
descent
sever
cftr
genotyp
known
associ
pancreat
insuffici
tabl
age
first
p
aeruginosa
infect
rang
year
year
averag
first
p
aeruginosa
infect
occur
approxim
year
age
two
snp
reach
region
signific
regress
model
coeffici
correspond
delay
first
p
aeruginosa
infect
addit
allel
p
minor
allel
frequenc
maf
correspond
gg
ga
aa
correspond
delay
first
p
aeruginosa
infect
addit
allel
p
maf
correspond
gg
ga
aa
fig
tabl
e
snp
annot
intron
dpyd
fig
smaller
sampl
individu
age
chronic
p
aeruginosa
infect
avail
n
snp
reach
region
signific
although
display
evid
associ
level
p
coeffici
estim
fig
tabl
region
associ
analysi
lung
diseas
phenotyp
forc
expiratori
volum
n
snp
reach
region
signific
evid
associ
fig
tabl
thu
result
confirm
translat
relev
murin
genet
map
human
respiratori
infect
p
aeruginosa
investig
host
genet
factor
modifi
suscept
infect
import
understand
diseas
process
demonstr
cc
line
distinct
diseas
phenotyp
rang
complet
resist
sever
pneumonia
confirm
influenc
host
genet
background
respons
p
aeruginosa
infect
basi
result
identifi
qtl
murin
chr
modifi
sever
respiratori
infect
priorit
candid
modifi
gene
within
qtl
led
us
select
gene
function
valid
relev
respiratori
infect
gene
encod
gproteincoupl
receptor
fundament
physiolog
role
inflamm
mediat
immun
cell
traffick
express
varieti
cell
type
includ
endotheli
epitheli
cell
cell
natur
killer
cell
innat
lymphoid
cell
dendrit
cell
human
nonsynonym
snp
identifi
us
nation
heart
lung
blood
institut
exom
sequenc
project
function
variant
associ
asthma
suscept
constitut
risk
factor
diseas
sever
support
idea
genet
variant
may
influenc
physiolog
patholog
event
lung
compart
work
identifi
genet
variant
associ
sever
p
aeruginosa
respiratori
infect
canadian
cf
gene
modifi
cohort
howev
exclud
presenc
nonsynonym
snp
differ
cohort
patient
includ
differ
respiratori
diseas
eg
copd
worth
note
function
level
result
suggest
modul
modifi
outcom
infecti
process
least
vivo
model
respiratori
infect
functionalvalid
approach
pharmacolog
target
mice
chosen
base
intermedi
suscept
infect
p
aeruginosa
strain
surviv
rate
give
us
opportun
evalu
benefici
detriment
effect
treatment
use
compound
antagonist
demonstr
modul
relev
outcom
p
aeruginosa
infect
although
possibl
might
also
act
receptor
compound
select
receptor
antagonist
confirm
relev
receptor
outcom
p
aeruginosa
infect
notabl
treatment
either
result
alter
traffick
egress
lymphocyt
lymphocyt
egress
mediat
activ
addit
anoth
studi
sphingosin
involv
pulmonari
infect
mice
burn
injuri
suggest
may
also
role
p
aeruginosa
infect
process
indic
result
qtl
map
result
cc
mice
enabl
us
focu
attent
small
synten
human
genet
locu
therebi
gain
statist
power
sinc
small
genom
region
need
test
associ
approach
yield
genet
modifi
potenti
relev
human
lung
diseas
even
use
rel
small
sampl
size
andor
limit
phenotyp
assum
p
aeruginosa
respiratori
infect
associ
wide
rang
patholog
clinic
phenotyp
owe
differ
etiolog
condit
eg
cf
copd
avail
phenotyp
genotyp
cohort
patient
limit
cohort
patient
cf
investig
previous
genotyp
character
candid
gene
studi
develop
p
aeruginosa
infect
synten
human
locu
chromosom
intron
genet
variat
dpyd
associ
age
first
p
aeruginosa
infect
worth
note
dpyd
also
show
highest
genomewid
signific
murin
qtl
peak
dpyd
encod
dihydropyrimidin
dehydrogenas
catalyz
ratelimit
step
catabol
pathway
uracil
thymidin
dpyd
defici
widerang
implic
genet
variat
dpyd
associ
risk
sever
toxic
reaction
fluoropyrimidin
use
treat
cancer
studi
genotypephenotyp
correl
relat
dpyd
limit
result
demonstr
dpyd
requir
epithelialtomesenchym
transit
suggest
involv
lung
diseas
via
pulmonari
fibrosi
locat
associ
snp
noncod
region
dpyd
suggest
may
affect
gene
regul
either
dpyd
possibl
ci
tran
gene
involv
dpyd
metabol
pathway
suggest
possibl
role
immunolog
mechan
function
studi
requir
assess
role
dpyd
host
defens
infect
determin
effect
snp
regul
gene
express
dpyd
activ
data
suggest
genet
variat
dpyd
relev
p
aeruginosa
infect
potenti
human
biomark
although
effect
identifi
variant
dpyd
gene
identifi
human
locu
requir
investig
translat
natur
experiment
approach
provid
proof
concept
could
exploit
human
patholog
mediat
bacteri
infect
use
natur
variat
mous
model
priorit
human
candid
gene
result
demonstr
vivo
model
infect
integr
parallel
human
studi
use
make
new
discoveri
complex
human
diseas
anim
studi
approv
institut
anim
care
use
committe
tel
aviv
univers
tau
san
raffael
scientif
institut
milan
itali
human
studi
map
isol
gene
influenc
sever
diseas
cf
approv
sickkid
research
ethic
board
toronto
ontario
canada
p
aeruginosa
clinic
isol
deriv
patient
cf
attend
medizinisch
hochschul
hannov
germani
previous
describ
research
bacteri
isol
individu
cf
approv
respons
physician
cf
center
hannov
medic
school
germani
patient
gave
inform
consent
sampl
collect
approv
storag
biolog
materi
obtain
hannov
medic
school
germani
total
cc
mice
femal
male
line
averag
mice
per
cc
line
week
old
use
full
detail
develop
cc
coloni
previous
describ
http
csbiounceduccstatusindexpi
initi
genotyp
conduct
cc
mice
gener
homozygos
mice
use
studi
least
gener
later
correspond
genet
homozygos
aj
mice
purchas
jackson
laboratori
usa
use
intern
control
batch
experi
cc
mice
male
mice
purchas
charl
river
lecco
itali
week
old
use
treatment
molecul
mice
infect
intratrach
inject
p
aeruginosa
previous
describ
prior
anim
experi
p
aeruginosa
clinic
strain
grown
h
trypticas
soy
broth
tsb
bd
becton
dickinson
reach
exponenti
phase
bacteria
pellet
centrifug
g
min
resuspend
steril
phosphatebuff
salin
pb
dilut
give
requir
dose
mice
anesthet
intraperiton
ip
inject
solut
avertin
nacl
administ
volum
mlg
bodi
weight
infect
dose
cfu
p
aeruginosa
describ
previous
surviv
time
bodi
weight
mice
record
daili
week
addit
mice
monitor
coat
qualiti
postur
attitud
ambul
hydrat
statu
mice
lost
bodi
weight
evid
sever
clinic
diseas
sacrif
termin
experi
overdos
carbon
dioxid
whole
blood
collect
analyz
immedi
hematocrit
carri
autom
procyt
dx
hematolog
analyz
idexx
bioresearch
usa
broadsens
herit
includ
epistat
domin
effect
surviv
time
calcul
across
cc
line
p
aeruginosa
infect
previous
describ
data
analysi
perform
r
statist
softwar
r
develop
core
team
includ
r
packag
happyhbrem
surviv
data
cc
line
convert
binari
alivedead
phenotyp
one
day
trial
binari
phenotyp
analyz
presenc
qtl
twostag
process
first
logist
regress
model
use
fit
covari
gender
batch
initi
bodi
weight
r
function
glm
next
residu
model
use
respons
variabl
qtl
map
linear
regress
bayesian
randomeffect
model
hbrem
estim
individu
haplotyp
effect
one
covari
initi
bodi
weight
significantli
affect
surviv
gender
batch
effect
mean
valu
residu
across
replic
within
cc
line
use
qtl
analysi
presenc
qtl
test
analysi
varianc
anova
compar
fit
genet
model
null
hypothesi
qtl
map
cc
strain
consist
eightway
haplotyp
linear
regress
addit
model
describ
previous
genomewid
signific
estim
permut
cc
line
label
permut
phenotyp
qtl
effect
size
estim
proport
log
likelihood
explain
locu
effect
qtl
genomewid
signific
genomewid
signific
level
estim
permut
cc
strain
test
addit
detail
provid
text
supplement
materi
merg
analysi
util
test
variant
qtl
peak
compat
pattern
action
qtl
sequenc
variant
identifi
sanger
institut
mous
genom
project
databas
receptor
antagonist
compound
catalogu
number
tocri
bioscienc
analogu
catalogu
number
sigmaaldrich
milan
itali
prepar
dimethyl
sulfoxid
dmso
sigmaaldrich
milan
itali
first
mice
treat
mgkg
bodi
weight
mgkg
administ
ip
test
toxic
molecul
control
mice
inject
dmso
steril
water
next
mice
infect
p
aeruginosa
administr
treat
mgkg
mgkg
vehicl
dmso
volum
ip
administr
addit
control
mice
challeng
pb
administr
treat
describ
mice
dmso
treatment
start
h
p
aeruginosa
infect
pb
challeng
follow
treatment
twice
day
day
surviv
monitor
twice
day
snp
identifi
sanger
institut
mous
genom
project
databas
protein
express
respiratori
system
identifi
human
protein
atla
databas
priorit
candid
modifi
gene
perform
beegl
onlin
tool
use
list
train
gene
obtain
queri
lung
infect
geneslistquerylung
infectioncsv
synteni
portal
use
tool
perform
compar
genom
studi
synten
analysi
http
bioinfokonkukackrsyntenyport
primari
phenotyp
analyz
associ
canadian
cf
gene
modifi
cohort
age
first
infect
p
aeruginosa
n
followup
analysi
evalu
associ
evid
locu
relat
phenotyp
lung
diseas
sever
n
calcul
function
age
chronic
p
aeruginosa
infect
n
chronic
p
aeruginosa
infect
defin
three
consecut
encount
posit
p
aeruginosa
infect
point
window
patient
clinic
record
patient
canadian
cystic
fibrosi
gene
modifi
studi
gm
complet
data
three
phenotyp
analyz
paper
explain
differ
sampl
size
analysi
sampl
analyz
associ
lung
diseas
sampl
canadian
cystic
fibrosi
gm
includ
previou
cf
lung
gwa
studi
subject
analyz
age
first
infect
individu
gm
studi
p
aeruginosa
infect
statu
measur
individu
overlap
individu
studi
corvol
et
al
individu
analyz
age
chronic
p
aeruginosa
infect
subset
individu
appropri
longitudin
data
assess
whether
chronic
p
aeruginosa
infect
patient
characterist
report
tabl
supplement
materi
king
packag
use
obtain
princip
compon
serv
covari
adjust
popul
structur
account
relat
individu
input
variabl
analysi
genotyp
snp
high
minor
allel
frequenc
low
linkag
disequilibrium
tracywidom
statist
comput
eigensoft
use
evalu
signific
princip
compon
tabl
individu
cf
cohort
analyz
valu
first
three
princip
compon
plot
along
sampl
individu
cf
popul
overlap
group
european
mexican
group
exclud
associ
analysi
fig
associ
analysi
conduct
snp
chr
region
span
mb
infect
phenotyp
age
first
p
aeruginosa
infect
age
chronic
p
aeruginosa
infect
lung
function
sever
snp
minor
allel
frequenc
includ
code
addit
model
age
first
p
aeruginosa
infect
age
chronic
p
aeruginosa
infect
squareroot
transform
associ
analys
use
gener
estim
equat
ident
link
implement
r
statist
packag
account
sibl
correl
exchang
covari
structur
sex
signific
princip
compon
includ
model
covari
snp
account
multiplehypothesi
test
p
valu
threshold
signific
calcul
gec
packag
base
effect
number
independ
snp
analyz
locu
tabl
data
use
qtl
analysi
avail
data
set
supplement
materi
data
softwar
use
avail
http
mtwebcsuclacukmuswwwprecc
